Your browser doesn't support javascript.
loading
Phosphoinositide 3-kinase δ inhibition promotes antitumor responses but antagonizes checkpoint inhibitors.
Lim, Ee Lyn; Cugliandolo, Fiorella M; Rosner, Dalya R; Gyori, David; Roychoudhuri, Rahul; Okkenhaug, Klaus.
Afiliação
  • Lim EL; Laboratory of Lymphocyte Signalling and Development, The Babraham Institute, Cambridge, United Kingdom.
  • Cugliandolo FM; Laboratory of Lymphocyte Signalling and Development, The Babraham Institute, Cambridge, United Kingdom.
  • Rosner DR; Laboratory of Lymphocyte Signalling and Development, The Babraham Institute, Cambridge, United Kingdom.
  • Gyori D; Laboratory of Lymphocyte Signalling and Development, The Babraham Institute, Cambridge, United Kingdom.
  • Roychoudhuri R; Laboratory of Lymphocyte Signalling and Development, The Babraham Institute, Cambridge, United Kingdom.
  • Okkenhaug K; Laboratory of Lymphocyte Signalling and Development, The Babraham Institute, Cambridge, United Kingdom.
JCI Insight ; 3(11)2018 06 07.
Article em En | MEDLINE | ID: mdl-29875319

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Purinas / Protocolos de Quimioterapia Combinada Antineoplásica / Vacinas Anticâncer / Quinazolinonas / Inibidores de Fosfoinositídeo-3 Quinase / Neoplasias Tipo de estudo: Prognostic_studies Idioma: En Ano de publicação: 2018 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Purinas / Protocolos de Quimioterapia Combinada Antineoplásica / Vacinas Anticâncer / Quinazolinonas / Inibidores de Fosfoinositídeo-3 Quinase / Neoplasias Tipo de estudo: Prognostic_studies Idioma: En Ano de publicação: 2018 Tipo de documento: Article